Patricia L. Allen, Director at Zenas BioPharma, Inc. (ZBIO), bought 19,860 shares at $24.34 ($500K) on 2026-02-12, disclosed to the SEC on 2026-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.77 | 5,000 | $119K | 23.8% |
| 2 | $24.34 | 5,700 | $139K | 27.8% |
| 3 | $26.50 | 5,000 | $133K | 26.5% |
| 4 | $26.36 | 4,160 | $110K | 21.9% |
| Total | $25.16 avg | 19,860 | $500K | 100% |
| Filing → |
| ZFGN | BUY | 2016-07-26 | $50K | — | Filing → |
| ALNY | SELL | 2009-04-24 | $441K | — | Filing → |
| ALNY | SELL | 2007-10-26 | $440K | — | Filing → |